Filing Details
- Accession Number:
- 0001415889-23-012411
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-18 17:00:11
- Reporting Period:
- 2023-08-18
- Accepted Time:
- 2023-08-18 17:00:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1211583 | Fennec Pharmaceuticals Inc. | FENC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1185945 | A Chris Rallis | C/O Fennec Pharmaceuticals, Inc. Po Box 13628, 68 Tw Alexander Drive Research Triangle Park NC 27709 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2023-08-18 | 673 | $7.85 | 43,303 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares originally acquired through the exercise of an option with strike price of $0.45, and an original expiration date of August 17, 2022.
Billionaire Hedge Funds
